Skin-on-a-chip model simulating inflammation, edema and drug-based treatment
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Recent advances in microfluidic cell cultures enable the construction of in vitro human skin models that can be used for drug toxicity testing, disease study. However, current in vitro skin model have limitations to emulate real human skin due to the simplicity of model. In this paper, we describe the development of ‘skin-on-a-chip’ to mimic the structures and functional responses of the human skin. The proposed model consists of 3 layers, on which epidermal, dermal and endothelial components originated from human, were cultured. The microfluidic device was designed for co-culture of human skin cells and each layer was separated by using porous membranes to allow interlayer communication. Skin inflammation and edema were induced by applying tumor necrosis factor alpha on dermal layer to demonstrate the functionality of the system. The expression levels of proinflammatory cytokines were analyzed to illustrate the feasibility. In addition, we evaluated the efficacy of therapeutic drug testing model using our skin chip. The function of skin barrier was evaluated by staining tight junctions and measuring a permeability of endothelium. Our results suggest that the skin-on-a-chip model can potentially be used for constructing in vitro skin disease models or for testing the toxicity of cosmetics or drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Soft lithography for micro- and nanoscale patterning
Qin, D., Xia, Y., & Whitesides, G. M. (2010) · Nature Protocols · doi:10.1038/nprot.2009.234 · Cited by 2,334
CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
Arai, K.-I., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004031 · Cited by 1,318
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242
Endothelial cell–cell junctions: happy together
Dejana, E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1357 · Cited by 1,188
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Living Tissue Formed in Vitro and Accepted as Skin-Equivalent Tissue of Full Thickness
Bell, E., Ehrlich, H. P., Buttle, D. J., & Nakatsuji, T. (1981) · Science · doi:10.1126/science.7008197 · Cited by 1,052
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
Tracy, L. E., Minasian, R. A., & Caterson, E. J. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0561 · Cited by 1,008
Grossman, R. M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D. P., May, L. T., Kupper, T. S., Sehgal, P. B., & Gottlieb, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6367 · Cited by 853
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., & Lowry, S. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4845 · Cited by 845
Skin tissue engineering — In vivo and in vitro applications
Groeber, F., Holeiter, M., Hampel, M., Hinderer, S., & Schenke-Layland, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.005 · Cited by 633
In the Company of Animals: A Study of Human-Animal Relationships
Anderson, M., & Serpell, J. (1988) · Contemporary Sociology · doi:10.2307/2069456 · Cited by 633
Michael, S., Sorg, H., Peck, C.-T., Koch, L., Deiwick, A., Chichkov, B., Vogt, P. M., & Reimers, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057741 · Cited by 623
Schmook, F. P., Meingassner, J. G., & Billich, A. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00665-7 · Cited by 529
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
Netzlaff, F., Lehr, C.-M., Wertz, P. W., & Schaefer, U. F. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.004 · Cited by 387
Gröne, A. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00136-8 · Cited by 384
The use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318
In vitro skin irritation: facts and future. State of the art review of mechanisms and models
Welss, T., Basketter, D. A., & Schröder, K. R. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2003.09.009 · Cited by 311
Ataç, B., Wagner, I., Horland, R., Lauster, R., Marx, U., Tonevitsky, A. G., Azar, R. P., & Lindner, G. (2013) · Lab on a Chip · doi:10.1039/c3lc50227a · Cited by 272
Pumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 262
Roles of Rho/ROCK and MLCK in TNF‐α‐induced changes in endothelial morphology and permeability
McKenzie, J. A. G., & Ridley, A. J. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21114 · Cited by 251
Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J. H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., et al. (2007) · Alternatives to Laboratory Animals · doi:10.1177/026119290703500614 · Cited by 230
Estimates for worldwide laboratory animal use in 2005
Taylor, K., Gordon, N., Langley, G., & Higgins, W. (2008) · Alternatives to Laboratory Animals · doi:10.1177/026119290803600310 · Cited by 210
Is animal research sufficiently evidence based to be a cornerstone of biomedical research?
Pound, P., & Bracken, M. B. (2014) · BMJ · doi:10.1136/bmj.g3387 · Cited by 207
In vitro micro-physiological immune-competent model of the human skin
Ramadan, Q., & Ting, F. C. W. (2016) · Lab on a Chip · doi:10.1039/c6lc00229c · Cited by 203
Cytokine Mediators of Immunity and Inflammation
Lowry, S. F. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420230063010 · Cited by 202
Irreversible, direct bonding of nanoporous polymer membranes to PDMS or glass microdevices
Aran, K., Sasso, L. A., Kamdar, N., & Zahn, J. D. (2010) · Lab on a Chip · doi:10.1039/b924816a · Cited by 159
Kułdo, J. M., Westra, J., Ásgeirsdóttir, S. A., Kok, R. J., Oosterhuis, K., Rots, M. G., Schouten, J. P., Limburg, P. C., & Molema, G. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2004 · Cited by 158
Reijnders, C. M. A., van Lier, A., Roffel, S., Kramer, D., Scheper, R. J., & Gibbs, S. (2015) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0139 · Cited by 147
Plastic–PDMS bonding for high pressure hydrolytically stable active microfluidics
Lee, K. S., & Ram, R. J. (2009) · Lab on a Chip · doi:10.1039/b820924c · Cited by 141
Grellner, W. (2002) · Forensic Science International · doi:10.1016/s0379-0738(02)00342-0 · Cited by 135
Sato, Y., & Ohshima, T. (2000) · International Journal of Legal Medicine · doi:10.1007/s004140050285 · Cited by 118
The development of a 3D immunocompetent model of human skin
Chau, D. Y. S., Johnson, C., MacNeil, S., Haycock, J. W., & Ghaemmaghami, A. M. (2013) · Biofabrication · doi:10.1088/1758-5082/5/3/035011 · Cited by 110
Zhang, M.-J., Zhou, J., Wang, L., Li, B., Guo, J.-W., Guan, X., Han, Q.-J., & Zhang, H.-J. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00459 · Cited by 104
Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis
Gomi, T., Shiohara, T., Munakata, T., Imanishi, K., & Nagashima, M. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.6.827 · Cited by 83
Evaluation of a Human Bio-Engineered Skin Equivalent for Drug Permeation Studies
Asbill, C. S., Kim, N., El‐Kattan, A. F., Creek, K. E., Wertz, P. W., & Michniak, B. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1026405712870 · Cited by 72
Dexamethasone inhibits TNF‐α‐induced apoptosis and IAP protein downregulation in MCF‐7 cells
Meßmer, U. K., Pereda‐Fernandez, C., Manderscheid, M., & Pfeilschifter, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704093 · Cited by 63
Review of the Availability of In Vitro and In Silico Methods for Assessing Dermal Bioavailability
Coralie, D., Prieto, P., Asturiol, D., & Worth, A. P. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0003 · Cited by 60
Machuca-Rodríguez, C., Mendoza-Milla, C., Córdova, E. J., Mejía, S., Covarrubias, L., Ventura, J. L., & Zentella‐Dehesa, A. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-9 · Cited by 58
Mizuno, K., Morizane, S., Takiguchi, T., & Iwatsuki, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.06.016 · Cited by 51
Cytokine expression in psoriatic skin lesions during PUVA therapy
Olaniran, A. K., Baker, B. S., Paige, D. G., Garioch, J., Powles, A. V., & Fry, L. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505228 · Cited by 49
Allergens of the entomopathogenic fungus Beauveria bassiana
Westwood, G. S., Huang, S., & Keyhani, N. O. (2005) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-3-1 · Cited by 48
Maaser, C., Schoeppner, S., Kucharzik, T. F., Kraft, M., Schoenherr, E., Domschke, W., & Luegering, N. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01541.x · Cited by 39
Liu, Q., Wang, Y., & Thorlacius, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2641 · Cited by 38
Castro‐Caldas, M., Mendes, A. F., Carvalho, A. P., Duarte, C. B., & Lopes, M. C. (2003) · Mediators of Inflammation · doi:10.1080/0962935031000096953 · Cited by 36
Joyce, D. A., Kloda, A., & Steer, J. H. (1997) · Immunology and Cell Biology · doi:10.1038/icb.1997.53 · Cited by 27
Alépée, N., Robert, C., Tornier, C., & Cotovio, J. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.12.013 · Cited by 22
Anticytokine therapy for periodontal diseases: Where are we now?
Waykole, Y., Doiphode, S., Rakhewar, P. S., & Mhaske, M. (2009) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.55837 · Cited by 21
Anatomy and physiology of the skin
DAWBER, R., Bristow, I., & Turner, W. (2002) · CRC Press eBooks · doi:10.3109/9780203450505-3 · Cited by 19
Uings, I., Puxeddu, I., Temkin, V., Smith, S. J., Fattah, D., Ray, K. P., & Levi‐Schaffer, F. (2005) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-3-5 · Cited by 19
Bonifati, C., Ameglio, F., Carducci, M., Sacerdoti, G., Pietravalle, M., & Fazio, M. (1994) · PubMed · Cited by 15
Research works printed but not linked: 1
- Ramadan, Q. & Ting, F. C. W. In vitro micro-physiological immune-competent model of the human skin. Lab Chip 16, 1899–1908 (2016). · DOI · Paper page
Cited by
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Advances in Hydrogels in Organoids and Organs‐on‐a‐Chip
Liu, H., Wang, Y., Cui, K., Guo, Y., Zhang, X., & Qin, J. (2019) · Advanced Materials · doi:10.1002/adma.201902042 · Cited by 353
Pattanayak, P., Singh, S. K., Gulati, M., Vishwas, S., Kapoor, B., Chellappan, D. K., Anand, K., Gupta, G., Jha, N. K., Gupta, P. K., et al. (2021) · Microfluidics and Nanofluidics · doi:10.1007/s10404-021-02502-2 · Cited by 330
Metadata
- Authors
- Wufuer, M., Lee, G., Hur, W., Jeon, B., Kim, B. J., Choi, T. H., & Lee, S.
- Affiliations
- Seoul National University (KR)
- Korea University (KR)
- Corresponding author
- Choi, Tae Hyun
- Venue
- Scientific Reports
- Published
- 2016-11-21
- Volume
- 6
- Issue
- 1
- Pages
- 37471-37471
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5116589
- OpenAlex
- W2550854745
- Cited by
- 356
- References
- 54
- Citations by year
- 2026: 39 · 2025: 32 · 2024: 40 · 2023: 36 · 2022: 50 · 2021: 52 · 2020: 35 · 2019: 24 · 2018: 36 · 2017: 12
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Food and Drug Safety (16182MFDS526)
- Korea Institute of Science and Technology
- Korea Research Institute of Bioscience and Biotechnology (KGM4891511)
- Ministry of Public Safety and Security (MPSS-CG-2016-02)
- KU-KIST Graduate School of Converging Science and Technology
- Korean National Police Agency ((PA‐H000001))
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- skin-on-a-chip, in vitro skin model, microfluidic co-culture, skin inflammation, edema, TNF-α, inflammatory cytokines, skin barrier function, tight junctions, endothelial permeability, drug toxicity testing
- MeSH terms
- Dexamethasone, Edema, Humans, Immunohistochemistry, Inflammation, Models, Biological, Skin, Tumor Necrosis Factor-alpha, Tight Junctions, Protective Agents, Lab-On-A-Chip Devices, Human Umbilical Vein Endothelial Cells, Optical Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.